Clin/Path Flashcards
Congenital hypothyroidism (cretinism) clinical presentation
Usually asymptomatic at birth (rarely causes delayed meconium passage)
After maternal thyroxine wanes (weeks to months):
Lethargy, poor feeding
Enlarged/protruding anterior fontanelle
Protruding tongue, puffy face, umbilical hernia (all of these are due to accumulation of matrix substances cutaneously and internally)
Constipation
Prolonged jaundice
Dry skin
Congenital hypothyroidism (cretinism) diagnosis
↑ TSH & ↓ free thyroxine levels
Newborn screening
Congenital hypothyroidism (cretinism) treatment
what to avoid with it
Levothyroxine by 2 weeks old can normalize cognitive and physical development
Avoid co-administration with soy products, iron, or calcium.
Congenital hypothyroidism (cretinism) prognosis if treated
No deficits if treatment started in neonatal period
So make sure to screen for this
Congenital hypothyroidism (cretinism) prognosis if untreated
neurocognitive dysfunction (eg, ↓ intelligence quotient)
Congenital hypothyroidism (cretinism) etiology
thyroid dysgenesis (agenesis, hypoplasia, or ectopy), and iodine deficiency is a common cause in areas endemic for iodine deficiency (eg, Europe).
TSH resistance due to a mutation in the TSH receptor gene
T4 functions
essential for normal brain development and myelination during early life
stimulation of protein synthesis as well as carbohydrate and lipid catabolism in many cells
Down syndrome
clinical
Hypotonia hypothyroidism upslanting palpebral fissures bilateral epicanthal folds single palmar crease
Galactosemia etiology
galactose-1-phosphate uridyltransferase deficiency
Galactosemia clinical
jaundice, vomiting, hepatomegaly, and lethargy after ingesting galactose in breast milk or formula in the first few days of life
Hirschsprung disease etiology
abnormal migration of neural crest cells into the rectosigmoid colon
Hirschsprung disease clinical
failed meconium passage and bilious emesis in a newborn due to lack of ganglion cells in rectosigmoid colon impeding gastrointestinal motility
Phenylketonuria (PKU) etiology
phenylalanine hydroxylase deficiency resulting in hyperphenylalaninemia
Phenylketonuria (PKU) clinical
developmental delay, light pigmentation, and a musty body odor
DiGeorge syndrome (DGS) etiology
neural crest fails to migrate into the derivatives of the third (affects inferior parathyroid and thymus) and fourth (affects superior parathyroid) pharyngeal/branchial pouches
DiGeorge syndrome (DGS) labs
hypocalcemia (due to parathyroid hypoplasia)
T cell deficiency (due to thymic hypoplasia)
Hypocalcemia presents as:
increased neuromuscular excitability, which manifests as tetany, carpopedal spasms, or seizures.
Chvostek sign -
Tapping on the facial nerve usually elicits twitching of the nose and lips
Trousseau sign -
inflation of the blood pressure cuff leads to carpopedal spasm
DiGeorge syndrome (DGS) imaging:
absence of thymic shadow (may be written as chest x-ray reveals decreased soft-tissue attenuation in the right anterior mediastinum) which reflects thymic hypoplasia
What complication may thymic aplasia lead to and why?
absence reflects thymic hypoplasia, which leads to T cell dysfunction and results in recurrent viral, fungal, and protozoan infections.
What microdeletion is associated with DiGeorge Syndrome?
22q11.2 microdeletion
What is seen clinically in a DiGeorge syndrome patient when the first and second pharyngeal/branchial pouches are involved as well?
hypertelorism, short palpebral fissures, micrognathia, bifid uvula, and cleft palate
Anencephaly etiology
neural tube defect due to failure of the anterior neuropore to close
foramen cecum
depression on the tongue that represents the embryological remnant of the superior end of the obliterated thyroglossal duct
thyroglossal cyst etiology
due to a persistent thyroglossal duct
thyroglossal cyst location
midline neck mass
Rathke pouch
invaginated oral ectoderm that eventually develops into the anterior pituitary
Craniopharyngiomas etiology
arise from remnants of the Rathke pouch
Craniopharyngiomas clinical
hypopituitarism, hydrocephalus, and diabetes insipidus
Persistence of second branchial cleft (ie, second pharyngeal groove)
This is normally obliterated in utero but persistence leads to a branchial cleft cyst between the angle of the mandible and sternocleidomastoid muscle.
Incretins
gastrointestinal hormones produced by the gut mucosa that stimulate pancreatic insulin secretion in response to sugar-containing meals. This response is independent of blood glucose levels, and typically occurs prior to any elevation in blood glucose level following a meal
Two hormones with incretin effects are
glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (glucose-dependent insulinotropic peptide, GIP).
Insulin-like growth factor-1 produced because?
produced by the liver in response to stimulation by growth hormone.
Insulin-like growth factor-1 function
It functions as a mitogen and as an inhibitor of apoptosis
Somatostatin is produced by
cells in the stomach, small bowel and pancreas (“delta cells”)
Somatostatin function
decreases the secretion of secretin, cholecystokinin, glucagon, insulin, gastrin and growth hormone
Secretin produced because?
hormone produced in the duodenum in response to increased luminal acidity.
Secretin function
stimulates the release of bicarbonate-rich secretions from the pancreas, gallbladder and duodenum. It also increases the activity of cholecystokinin.
Cholecystokinin is produced by
duodenum in response to a fat or protein-rich meal.
Cholecystokinin functions
inhibition of further gastric emptying, stimulation of pancreatic enzyme secretion and stimulation of bile production and gallbladder contraction
Type 1 diabetes mellitus demographic
genetically susceptible individuals who are exposed to triggering environmental factors (eg, viral infections, environmental toxins, dietary components).
Type 1 diabetes mellitus etiology
autoimmune (cell-mediated) response against pancreatic beta cells that leads to progressive loss of beta cell mass (this causes low levels of low circulating islet amyloid polypeptide)
Type 1 diabetes mellitus clinical
develop once >90% of beta cells are destroyed
excessive thirst and polyuria
insulitis
Infiltration of islets by inflammatory cells in T1DM and is more prominent during the early stages of disease.
type 2 diabetes mellitus development risk factors
Abdominal visceral fat deposition and excessive body weight because they cause insulin resistance
Maturity-onset diabetes of the young genetics
autosomal dominant disease
Maturity-onset diabetes of the young etiology
mutations that impair glucose sensing and insulin secretion by pancreatic beta cells
Maturity-onset diabetes of the young clinical
non-insulin-dependent diabetes at a young age (<25) and accounts for <5% of all cases of diabetes mellitus
Islet amyloid polypeptide secreted from?
secreted along with insulin from pancreatic beta cells.
T2DM etiology
Insulin resistance accompanied by relative insulin deficiency is the main cause
T2DM histology
Amyloid deposition occurs in the islets
exogenous thyrotoxicosis etiology
abuse of thyroid preparations (eg, levothyroxine, porcine thyroid extracts) or inadvertently due to errors in treatment of hypothyroidism
exogenous thyrotoxicosis clinical
resemble endogenous hyperthyroidism and include weight loss, tremor, heat intolerance, and tachycardia/palpitations
exogenous thyrotoxicosis labs
suppressed TSH
suppressed RAIU
suppressed serum thyroglobulin (because thyroid metabolic activity is low)
elevated Triiodothyronine (T3) (because exogenous levothyroxine is readily converted to T3)
elevated free thyroxine (T4)
Radioactive iodine uptake (RAIU)
radioiodine tracer that is administered followed by scintigraphy of the thyroid gland
RAIU correlates with the organification of iodine and the synthesis of new thyroid hormone
Thyroglobulin
large glycoprotein in thyroid follicles that serves as a source of tyrosine residues for thyroid hormone synthesis
Graves disease labs
↓Serum TSH
↑Serum thyroglobulin
↑ Radioiodine uptake (due to excessive TSH receptor stimulation)
Graves disease etiology
due to autoantibodies that activate the TSH receptor and induce thyroid hormone production
subacute granulomatous thyroiditis
destruction of thyroid follicles and the release of preformed thyroid hormone
subacute granulomatous thyroiditis labs
Elevated thyroglobulin
elevated T3
decreased TSH
increased serum thyroglobulin
TBG levels in hyperestrogenic states
elevated
subacute granulomatous thyroiditis clinical
Painful** thyroid enlargement
Transient hyperthyroid symptoms (due to release of stored thyroid hormone)
subacute granulomatous thyroiditis etiology
typically follows an acute viral illness and is thought to be due to a cross-reacting immune response against viral proteins or tissue antigens released during cellular injury
subacute granulomatous thyroiditis diagnosis
↑ ESR & CRP (serum acute phase markers)
↓ Radioiodine uptake (low TSH levels suppress synthesis of new thyroid hormone)
subacute granulomatous thyroiditis treatment
self-limited and resolves in <6 weeks, although patients may have a brief hypothyroid phase before returning to a euthyroid state
subacute granulomatous thyroiditis histology
initially characterized by a neutrophilic infiltrate with microabscess formation, which, as the disease progresses, is replaced by a more generalized inflammatory infiltrate with macrophages and multinucleated giant cells
Hashimoto thyroiditis etiology
Autoimmune etiology
Hashimoto thyroiditis clinical
Diffuse, painless thyroid enlargement
Predominant hypothyroid features (eg, fatigue, cold intolerance)
**most common cause of hypothyroidism
Hashimoto thyroiditis diagnosis
Positive TPO antibody**
Variable radioiodine uptake
Hashimoto thyroiditis histology
Lymphocytic infiltrate with well-developed germinal centers
Hürthle cells (eosinophilic epithelial cells)
Papillary thyroid cancer histology
branching papillary structures with concentric calcifications (psammoma bodies)
Papillary thyroid cancer gross
nodular enlargement
Riedel thyroiditis histology
extensive fibrosis of the thyroid gland that extends into surrounding tissues
Riedel thyroiditis gross
thyroid gland is rock-hard and nontender
Graves disease histology
Diffusely hyperplastic follicles with tall, crowded cells forming intrafollicular projections
Hashimoto thyroiditis aka
Chronic lymphocytic thyroiditis
secondary (central) hyperthyroidism labs
elevated TSH, elevated T3, T4
secondary (central) hyperthyroidism etiology
most commonly due to TSH-secreting pituitary adenoma
Hyperthyroidism clinical
fatigue, weight loss, and palpitations associated with elevated thyroid hormone levels. Hyperadrenergic signs (eg, lid lag, tremor) are also common
Hyperthyroidism labs
Low TSH, elevated T3 and T4
secondary (central) hyperthyroidism clinical
diffuse goiter (because excess TSH causes generalized hypertrophy of the thyroid gland)
Effect of estrogen on TBG and consequently the thyroid levels
Estrogen (eg, pregnancy, oral contraceptives) causes increased production of TBG, which lowers free thyroid hormone levels. A brief rise in TSH subsequently increases production of thyroid hormone to saturate the increased TBG binding sites, and the patient returns to a euthyroid state. Total T3 and T4 are elevated, but TSH and free hormone levels are normal
Painless thyroiditis histology
autoimmune destruction of thyroid follicles with release of preformed thyroid hormone
Thyroid cancer gross
hard, asymmetric goiter
Thyroid cancer clinical
Thyroid tissue adjacent to cancer may be compressed and nonfunctional, but the contralateral lobe can usually compensate and patients are typically euthyroid
Fecal occult blood testing
screens for colorectal cancer and improves mortality through earlier detection
Prostate-specific antigen
increased in some patients with prostate cancer but testing has not been shown to improve mortality from prostate cancer
Aspirin use significantly reduces the risk of
death from coronary heart disease in diabetic patients but is less effective than smoking cessation
most effective preventive intervention in almost all patients
Smoking cessation
Prolactinoma clinical in premenopausal vs postmenopausal woman
Premenopausal women: oligomenorrhea, amenorrhea (due to the inhibitory effect of prolactin on hypothalamic GnRH release), infertility, galactorrhea, hot flashes, decreased bone density
Postmenopausal women: mass-effect symptoms (headache, visual field defects)
Prolactinoma clinical in men
infertility, decreased libido, impotence, gynecomastia
Prolactinoma diagnosis steps
Serum prolactin (often >200 ng/mL)
Tests to rule out renal insufficiency (creatinine) & hypothyroidism (TSH, thyroxine)
MRI of the head/pituitary
Prolactinoma treatment
Dopamine agonist (cabergoline) (because of tonic inhibitory effect of dopamine on prolactin secretion) Transsphenoidal surgery
Galactorrhea
abnormal secretion of breast milk not associated with pregnancy or breastfeeding
Galactorrhea etiology
most commonly due to excess prolactin, which directly stimulates milk secretion in the breasts
Prolactin regulation
prolactin is primarily under negative regulation by hypothalamic dopaminergic neurons via the pituitary stalk
Estrogen effect on galactorrhea
Estrogen stimulates prolactin gene transcription and secretion. Strongly estrogenic medications (eg, birth control pills) can potentially worsen rather than alleviate galactorrhea
Dopamine antagonists effect on galactorrhea
(eg, antipsychotics) directly increase prolactin secretion and can worsen galactorrhea
estrogen effect on prolactin
Estrogen stimulates prolactin gene transcription and secretion
TRH effect on prolactin
Thyrotropin-releasing hormone (TRH) stimulates secretion of prolactin by lactotrophs, although its role in regulating prolactin release is secondary to the inhibition of prolactin secretion by dopamine
Pulsatile Gonadotropin-releasing hormone (GnRH)
polypeptide that is normally released from the anterior hypothalamus in a pulsatile manner. GnRH is carried to the anterior pituitary via the portal circulation, where it stimulates FSH and LH production
FSH and LH function in ovaries
development of the dominant follicle in the ovaries. Optimal frequency and amplitude of GnRH pulses are crucial for FSH and LH release and subsequent ovulation
Anovulation due to hypogonadotropic hypogonadism clinical
common form of infertility
Anovulation due to hypogonadotropic hypogonadism treatment
pulsatile administration of GnRH and the ovulation occurs in most patients in 10-20 days
Signs of ovulation diagnosis
loss of a dominant follicle on ultrasound
surge in urine LH levels
rise in serum progesterone levels
rise in basal body temperature